Tag: CBT > Cannabis Descheduling: Page 2

Cannabis Rescheduling

UPDATE: DEA Moves to Reschedule Cannabis

The federal agency that has long enforced prohibition aligns with the recommendation from the U.S. Department of Health and Human Services, FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act.

April 30, 2024

Legislation and Regulation

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

April 20, 2024

Florida

The Future of Hemp-Derived Delta-9 THC Headlines CBT’s Most-Read Articles for March

Readers also dove headfirst into Amazon’s delta-8 problems and a potential rescheduling roadblock with the DEA’s five-factor test this month.

March 28, 2024

Cannabis Rescheduling

3 GOP Senators Tell DEA Not to Reschedule Cannabis

Led by former presidential candidate Mitt Romney, the senators argue rescheduling would violate an international treaty in letter to DEA administrator.

March 27, 2024

Cannabis Rescheduling

Is Cannabis in Schedule I or V? HHS Secretary Forgets

U.S. Health Secretary Xavier Becerra couldn’t remember the plant’s classification during a subcommittee hearing on his department’s budget request, during which a dispute over HHS’ rescheduling recommendation arose.

March 20, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

Cannabis Rescheduling

'Deschedule or Do Nothing:' Drug Policy Alliance Says Rescheduling Cannabis Would Not End Criminalization

Drug Policy Alliance and representatives from other cannabis organizations and businesses explained the limitations and potential harms of relisting cannabis as a Schedule III drug from Schedule I of the Controlled Substances Act in a special virtual press briefing.

March 1, 2024

South Carolina

Jamaica’s THC Exports to United States Leads CBT’s Most Popular Articles in February

Rescheduling, state legalization prospects, and Lume’s rapid rise in Michigan also ranked in Cannabis Business Times’ top 10 stories this month.

February 29, 2024

Regulations and Reform

DOJ Declines to Address Media Inquiry on Cannabis Rescheduling, Points to 2020 Resource Guide

A Department of Justice spokesperson said the government has nothing further to provide beyond its confirmation of review.

February 27, 2024

Cannabis Rescheduling

Former Police Chiefs, Prosecutors, Correctional Officials Urge Biden to Reschedule Cannabis

Officials who dedicated their careers to protecting public safety and reducing unnecessary arrests say cannabis prohibition has become problematic.

February 22, 2024

International

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

February 22, 2024

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024